The Supreme People’s Court of China ruled on the first pharmaceutical patent linkage case after the new Patent Law

Hongxuyang Lu

Journal of Intellectual Property Law and Practice, 2023, vol. 18, issue 2, 74-77

Abstract: In the first case regarding the pharmaceutical patent linkage regime in China, the Supreme People’s Court of China ruled that the validity of a patent did not affect a pharmaceutical patent linkage case. Whether the technical solution of the generic drug falls within the scope of protection of a patent should be judged based on the submitted application for marketing authorization, instead of the actual technical solution implemented.

Date: 2023
References: Add references at CitEc
Citations:

Downloads: (external link)
http://hdl.handle.net/10.1093/jiplp/jpad004 (application/pdf)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:oup:jiplap:v:18:y:2023:i:2:p:74-77.

Access Statistics for this article

Journal of Intellectual Property Law and Practice is currently edited by Eleonora Rosati, Stefano Barazza and Marius Schneider

More articles in Journal of Intellectual Property Law and Practice from Oxford University Press
Bibliographic data for series maintained by Oxford University Press ().